Table 7 Prognostic factors for non-cancer-specific survival

Male

4.16 (1.71–12.4)

0.001

1.32 (0.25–7.79)

0.764

Age

1.15 (1.09–1.22)

 < 0.001

1.13 (1.07–1.21)

 < 0.001

PS 1, 2

17.0 (3.95–50.7)

0.001

3.22 (0.67–11.4)

0.129

Smoking history

4.23 (1.75–12.6)

0.001

2.82 (0.52–18.1)

0.251

CCI

1.25 (1.02–1.45)

0.035

0.95 (0.71–1.18)

0.662

Incomplete MDT

6.36 (2.75–14.0)

 < 0.001

3.08 (1.18–7.75)

0.022

CEA level

1.05 (0.97–1.09)

0.143

SUV max

1.07(1.01–1.14)

0.036

0.96 (0.85–1.07)

0.467

Invasive component size

1.08 (1.04–1.13)

 < 0.001

1.06 (0.99–1.13)

0.077

Non-adenocarcinoma

2.93 (1.39–6.03)

0.006

0.78 (0.26–2.35)

0.649

Lymphatic invasion

–

0.045

Vascular invasion

–

0.201

STAS

1.18 (0.44–2.74)

0.717